Is an outbreak of inflammatory bowel disease (ulcerative colitis or Crohn's disease) more likely in patients prescribed a beta-lactam antibiotic or azithromycin?
Abstract
The evidence indicates an association between general antibiotic use and an increased risk of IBD, but there is insufficient specific evidence comparing the risk of IBD from beta-lactam antibiotics versus azithromycin.
Fields of Study & Subjects
Inflammatory Bowel Disease
Gut microbiota and health
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 3 February 2026